PHYTOCHEMICALS ANALYSIS VIA GC-MS, ASSESSMENT OF ANTI-INFLAMMATORY, ANTI-BACTERIAL, AND ANTI- FUNGAL PROPERTIES OF CASSIA FISTULA POD-BASED FUNCTIONAL TEA

Main Article Content

Muhammad Naeem Zubairi
Muhammad Khurram Afzal
Saeed Akhtar
Ahmad Mujtaba Noman
Ali Musarrat
Hafiz Muhammad Fayyaz
Muhammad Tauseef Sultan
Nayab Rao
Muhammad Usman Khalid
Wisha Saeed
Mavra Ameen

Keywords

Cassia Fistula (Amaltas), Phytochemical Compounds, pods, Anti-inflammatory activity, Anti-bacterial activity, Anti- fungal activity, Functional tea

Abstract

Cassia fistula Linn, also known as Pakistan Amaltas and Indian Laburnum, is a tropical plant used in traditional medicine for treating syphilis, tumors, burns, constipation, and skin disorders. The study aimed to ascertain the Cassia fistula Linn pods' zone of inhibition against bacterial strains and inflammation, in addition to assessing the pods' potential as antibacterial and ant-inflammatory agents. The hydroalcohol extracts' possible antibacterial efficacy against important bacterial and fungal species for medicine was evaluated. The antibacterial activity of Cassia fistula’s pod extracts (5, 25, 50, 100, and 250 μg/ml) against a variety of pathogenic bacteria and fungal species was assessed using the agar disc diffusion method. The extracts showed a significant decrease of inflammation and bacterial growth against the tested species. The microbiological activity of Cassia fistula’s pods has been associated with a number of secondary metabolites. The identification of naturally occurring bioactive chemicals in these plants may open the door to new directions in pharmacological research. The zone of inhibition was compared to a number of standards, such as ampicillin, ciprofloxacin, norfloxacin, chloramphenicol, nystatin, and griseofulvin.  Anti-inflammatory teat showed a typical immunological response in LPS-stimulated cells, with TNF- and NO levels of 85.9% and 76%, respectively. There is more potential for hydrocortisone and Cassia fistula’s pods to reduce particular inflammatory markers. The antibacterial test showed growth inhibition zones against S. pyogenes, S. aureus, E. coli, and P. aeruginosa at dosages ranging from 5 to 25 µg/ml. The amount of tannin, alkaloids, saponin, and total phenolic content were all reduced by the Cassia fistula’s pod extraction. Immunomodulatory investigations revealed a greater blood antibody titer in the extract-fed group. The GC-MC technique was utilized to analyze phytochemical compounds in the Cassia fistula pod extract, revealing thymine, butanoic acid, 2-methyl-, 2- methylpropyl ester, furancarboxaldehyde, pentanoic acid, 1,1 dimethylethyl ester, 5-Acetoxymethyl- 2-furaldehyde, butanoic acid, Valeric acid, 2,4;3,5-Dimethylene-1-iditol, Vitamin E, n-Hexadecanoic acid, Myo-Inositol, 4-C-methyl, oleic acid, and a-sitosterol.

Abstract 464 | pdf Downloads 138

References

1. Anitha, J., and Miruthula, S. 2020. Anti-inflammatory and phytochemicals analysis of Cassia fistula Linn. Fruit pulp extracts. Int. J. Pharmscog., 1: 207-215.
2. Alam MM, Siddiqui MB, Hussian W (1990). Treatment of diabetes throuherbal drugs in rural India. Fitoterpia; 61:240-2.
3. Anonymous (2005). New medical dictionary. 2nd ed. Oxford and IBH Publishing Co. Pvt.Ltd. New Delhi.
4. Batna PA and Balaraman R, (2005) Faculty of Technology and Engineering; Phytomedicine; 12(4): 264-270.
5. Bhalodia, N. R. and Shukla, V. J. 2021. Antibacterial and antifungal activities from leaf extracts of Cassia fistula L.: An ethnomedicinal plant. Journal of advanced pharmaceutical technology and research, 2: 104-113
6. Duraipandiyan, V. and Ignacimuthu, S. 2017. Antibacterial and antifungal activity of Cassia fistula L. An ethnomedicinal plant. Journal of Ethnopharmacology, 112: 590-594.
7. El-Meligy, R. M., Awaad, A. S. and Soliman, G. A. 2015. Prophylactic and curative anti- ulcerative colitis activity and the possible mechanisms of action of some desert plants. J. Enzyme Inhib. Med. Chem., 30: 250-258
8. Farnsworth NR (1993). Ethno pharmacology and future drug development: The North American experience. J Ethnopharmacol; 38:145-52. 2

9. Houghton PJ (1995). The role of plants in traditional medicine and current therapy. J Alter Complement Med; 1:131-43.
10. Hussain, J., Khan, A. L., Rehman, N., Zainullah, S. T., Hussain, F. and Shinwari, Z. K. 2009. Proximate and nutrient analysis of selected medicinal plant species of Pakistan. Pak J. Nutr., 8(1): 620-624.
11. Joshi KP, Chavan D and Patwardhan WB (2004), Molecular markers in herbal drug technology. Cwr Sci; 87: 159- 165
12. Kokashi CJ, Kokashi RJ and Sharma M (1958), Fluorescence of powdered vegetable drugs in ultra-violet radiation, J Am Pharm Assoc; 47: 715-717
13. Lam KS (2007). New aspects of natural products in drug discovery. Trends Microbiol; 15:279- 89
14. Lim, J. W., Kim, H. and Kim, K. H. 2001. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest., 81: 349-360
15. Ramasamy S, Charles MA (2009). Antibacterial effect of volatile components of selected medicinal plants against human pathogens. Asian J Microbial Biotech Env; 6:209-10.
16. Towers GH, Lopez A, Hudson JB (2001). Antiviral and antimicrobial activities of medicinal plants. J Ethnopharmacol; 77:189-96.
17. Verpoorte R, van d Houghton PJ (1995) Heijden R, Ten Hoopen HJG and Memelink J, (1999), Metabolic engineering of plant secondary metabolite pathways for the production of new chemicals. Biotechnol Lett, 21: 467-479. 2.

Most read articles by the same author(s)